Bluejay Diagnostics (BJDX) Short Interest Ratio & Short Volume → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free BJDX Stock Alerts $0.57 +0.05 (+9.52%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Bluejay Diagnostics Short Interest DataCurrent Short Volume66,100 sharesPrevious Short Volume400 sharesChange Vs. Previous Month+16,425.00%Dollar Volume Sold Short$32,389.00Short Interest Ratio / Days to Cover1.2Last Record DateApril 30, 2024Outstanding Shares2,690,000 sharesFloat Size1,690,000 sharesShort Percent of Float3.91%Today's Trading Volume33,391 sharesAverage Trading Volume76,414 sharesToday's Volume Vs. Average44% Short Selling Bluejay Diagnostics ? Sign up to receive the latest short interest report for Bluejay Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBJDX Short Interest Over TimeBJDX Days to Cover Over TimeBJDX Percentage of Float Shorted Over Time Ad Crypto 101 MediaA ‘DeFi Summer’ Projected!Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. Bluejay Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202466,100 shares $32,389.00 +16,425.0%3.9%1.2 $0.49 4/15/2024400 shares $248.00 -96.4%0.0%0 $0.62 3/31/202411,000 shares $8,830.80 -50.0%0.7%0.2 $0.80 3/15/202422,000 shares $17,604.40 -10.6%0.1%0.3 $0.80 2/29/202424,600 shares $18,942.00 +78.3%0.2%0.4 $0.77 2/15/202413,800 shares $10,902.00 -43.9%0.1%0.3 $0.79 Get the Latest News and Ratings for BJDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202424,600 shares $19,692.30 -29.3%0.2%0.5 $0.80 1/15/202434,800 shares $35,496.00 -61.8%4.5%0.8 $1.02 12/31/202391,200 shares $111,264.00 +2,940.0%11.7%2.1 $1.22 12/15/20233,000 shares $8,730.00 -26.8%0.4%0.1 $2.91 11/30/20234,100 shares $13,243.00 +28.1%0.5%0 $3.23 11/15/20233,200 shares $10,880.00 -54.3%0.4%0 $3.40 10/31/20237,000 shares $24,220.00 -66.2%0.9%0 $3.46 10/15/202320,700 shares $80,523.00 -43.1%2.6%0 $3.89 9/30/202336,400 shares $157,612.00 +766.7%4.6%0 $4.33 9/15/20234,200 shares $12,852.00 -93.4%0.5%0 $3.06 8/31/202363,300 shares $370,938.00 -22.9%9.2%0.1 $5.86 8/15/202382,100 shares $620,676.00 -5.7%14.4%0.1 $7.56 7/31/202387,100 shares $557,440.00 +53.6%15.3%0.1 $6.40 7/15/202356,700 shares $298,468.80 -76.2%10.0%0.3 $5.26 6/30/2023238,200 shares $64,218.72 -19.9%2.1%0.2 $0.27 6/15/2023297,200 shares $66,572.80 +134.4%2.6%0.6 $0.22 5/31/2023126,800 shares $29,962.84 +328.4%1.3%0.3 $0.24 5/15/202329,600 shares $8,290.96 +15.2%0.3%0.3 $0.28 4/30/202325,700 shares $7,681.73 -52.2%0.3%0.2 $0.30 4/15/202353,800 shares $19,653.14 +77.6%0.6%0.5 $0.37 3/31/202330,300 shares $12,398.76 -46.7%0.3%0.3 $0.41 3/15/202356,800 shares $30,672.00 -0.5%0.6%0.5 $0.54 2/28/202357,100 shares $37,997.20 -49.6%0.6%0.5 $0.67 2/15/2023113,300 shares $90,640.00 +192.8%1.2%1 $0.80 1/31/202338,700 shares $16,590.69 -21.7%0.4%0.4 $0.43 1/15/202349,400 shares $25,189.06 -14.1%0.5%0.9 $0.51 12/30/202257,500 shares $21,844.19 -25.8%0.6%1 $0.38 12/15/202277,500 shares $33,332.75 -34.3%0.8%1.2 $0.43 11/30/2022118,000 shares $80,240.00 -0.1%1.2%1.7 $0.68 11/15/2022118,100 shares $85,539.83 -23.8%1.2%1.5 $0.72 10/31/2022154,900 shares $128,412.10 -18.6%1.5%2.1 $0.83 10/15/2022190,300 shares $155,094.50 -11.8%1.9%1.4 $0.82 9/30/2022215,700 shares $168,246.00 +337.5%2.2%1.4 $0.78 9/15/202249,300 shares $44,838.35 -37.8%0.5%0.3 $0.91[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. BJDX Short Interest - Frequently Asked Questions What is Bluejay Diagnostics' current short interest? Short interest is the volume of Bluejay Diagnostics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 66,100 shares of BJDX short. 3.91% of Bluejay Diagnostics' shares are currently sold short. Learn More on Bluejay Diagnostics' current short interest. What is a good short interest ratio for Bluejay Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BJDX shares currently have a short interest ratio of 1.0. Learn More on Bluejay Diagnostics's short interest ratio. What is a good short interest percentage for Bluejay Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.91% of Bluejay Diagnostics' floating shares are currently sold short. Is Bluejay Diagnostics' short interest increasing or decreasing? Bluejay Diagnostics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 66,100 shares, an increase of 16,425.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bluejay Diagnostics' float size? Bluejay Diagnostics currently has issued a total of 2,690,000 shares. Some of Bluejay Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bluejay Diagnostics currently has a public float of 1,690,000 shares. How does Bluejay Diagnostics' short interest compare to its competitors? 3.91% of Bluejay Diagnostics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Bluejay Diagnostics: Nemaura Medical Inc. (0.34%), Sintx Technologies, Inc. (42.11%), Acutus Medical, Inc. (1.44%), Dynatronics Co. (2.09%), ReShape Lifesciences Inc. (1.68%), Aethlon Medical, Inc. (3.04%), Motus GI Holdings, Inc. (0.98%), Assure Holdings Corp. (0.84%), Quoin Pharmaceuticals, Ltd. (0.26%), INVO Bioscience, Inc. (1.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Bluejay Diagnostics stock? Short selling BJDX is an investing strategy that aims to generate trading profit from Bluejay Diagnostics as its price is falling. BJDX shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bluejay Diagnostics? A short squeeze for Bluejay Diagnostics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BJDX, which in turn drives the price of the stock up even further. How often is Bluejay Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BJDX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Nemaura Medical Short Interest Sintx Technologies Short Interest Acutus Medical Short Interest Dynatronics Short Interest ReShape Lifesciences Short Interest Aethlon Medical Short Interest Motus GI Short Interest Assure Short Interest Quoin Pharmaceuticals Short Interest INVO Bioscience Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BJDX) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & Company348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press